Publications by authors named "R W Robey"

Claim this Profile
C
Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic ductal adenocarcinoma.
Maryam Safari, Luigi Scotto, Agnes Basseville, Thomas Litman, Haoran Xue, Robert W Robey

Drug Resist Updat· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angulin-1/LSR inhibition transiently disrupts the blood-tumor barrier to enhance doxil permeability and impair malignant glioma progression.
Dominique Ferguson, Minhye Kwak, Sanghee Lim, Melissa Cesaire, Jatia Mills, Rob Robey

bioRxiv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of the Notch ligand DLK1 as an immunotherapeutic target and regulator of tumor cell plasticity and chemoresistance in adrenocortical carcinoma.
Nai-Yun Sun, Suresh Kumar, Yoo Sun Kim, Diana Varghese, Arnulfo Mendoza, Robert W Robey

Nat Commun· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional Implications of the Conformational Landscape of a Multidrug Transporter Revealed by Structures of Zebrafish Abcb4.
Jingyu Zhan, Chao-Ming Hsieh, Lothar Esser, Zabrina C Lang, Abraham J Morton, Robert Robey

bioRxiv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A whole genomic CRISPR-Cas9 screen identifies the amino acid transporter (LAT3) as a major determinant of oxaliplatin sensitivity in colorectal cancer cells.
N R Pawar, H M Wade, Z Jackson, N Poungpeth, A V Mitchell, R W Robey

bioRxiv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis